Nature communications

Heliyon

Nanoscale

The Journal of clinical investigation

eLife

Proceedings of the National Academy of Sciences of the United States of America

International journal of environmental research and public health

world neurosurgery

Environmental research

respirology (carlton, vic)

molecular microbiology

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Nature

Biomolecules

Disaster medicine and public health preparedness

Respiratory medicine

revue scientifique et technique (international office of epizootics)

Medical education

european journal of clinical investigation

journal of biomedical semantics

science (new york, ny)

journal of nuclear medicine : official publication, society of nuclear medicine

Bioscience trends

GeroScience

The Journal of experimental medicine

Signal transduction and targeted therapy

ssrn

[1] Ontology based mining of pathogen-disease associations from literature.

[2] FDG-PET/CT AS A NON-INVASIVE BIOMARKER FOR ASSESSING ADEQUACY OF TREATMENT AND PREDICTING RELAPSE IN PATIENTS TREATED FOR PULMONARY TUBERCULOSIS.

[3] Synergising tools for capacity assessment and One Health operationalisation.

[4] Catalytic production of impurity-free V electrolyte for vanadium redox flow batteries.

[5] Computational screening of transition-metal single atom doped CN monolayers as efficient electrocatalysts for water splitting.

[6] A rapid and label-free platform for virus capture and identification from clinical samples.

[7] Combining genomics and epidemiology to analyse bi-directional transmission of in a multi-host system.

[8] Pathogen-Specific Impacts of the 2011-2012 La Niña-Associated Floods on Enteric Infections in the MAL-ED Peru Cohort: A Comparative Interrupted Time Series Analysis.

[9] Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease.

[10] Underglycosylated prion protein modulates plaque formation in the brain.

[11] Interspecies interactions induce exploratory motility in .

[12] Respect the poster.

[13] New insights into the mycobacterial PE and PPE proteins provide a framework for future research.

[14] Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement.

[15] Impact of deoxycholate on growth, toxin production, and sporulation.

[16] Rationale for universal face masks in public against COVID-19.

[17] Histopathology and genetic susceptibility in COVID-19 pneumonia.

[18] Peer mentoring for medical students during COVID-19 pandemic via a social media platform.

[19] The many faces of the anti-COVID immune response.

[20] A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

[21] Editorial, Authors Reply: Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community.

[22] The Use of Digital Health in the Detection and Management of COVID-19.

[23] Candidate Targets for Immune Responses to 2019-Novel Coronavirus (nCoV): Sequence Homology- and Bioinformatic-Based Predictions.

[24] legal basis for ensuring infectious safety in correctional institutions (on the example of russia and mongolia)

[25] new insight into an old concept: role of immature erythroid cells in immune pathogenesis of neonatal infection

[26] in vivo production of monoclonal antibodies by gene transfer via electroporation protects against lethal influenza and ebola infections

[27] new kids on the block: rna-based influenza virus vaccines

[28] formulation and stability of an extemporaneous 0.02% chlorhexidine digluconate ophthalmic solution

[29] ephedrine enhances hiv-1 reactivation from latency through elevating tumor necrosis factor receptor ii (tnfrii) expression

[30] neutropenic fever

[31] the changing disease-scape in the third epidemiological transition

[32] etiological study of fever of unknown origin in patients admitted to medicine ward of a teaching hospital of eastern india

[33] one health perspectives on emerging public health threats

[34] the one health concept: 10 years old and a long road ahead

[35] gambaran status gizi anak 12-24 bulan di puskesmas mergangsan kota yogyakarta tahun 2015: tinjauan riwayat pemberian asi eksklusif dan kejadian penyakit infeksi

[36] the formation of the military medical system of the korean people’s army and the military medical officer*

[37] legal issues in quarantine and isolation for control of emerging infectious diseases

[38] main principles of compensation to breeders with the occurence of bovine spongiform encephalopathy (bse) in breeding cattle and with regards to their disbursement

[39] From SARS to the Omicron variant of COVID-19: China's policy adjustments and changes to prevent and control infectious diseases.

[40] Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options.

[41] Fair Allocation of Scarce Therapies for COVID-19.

[42] Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load.

[43] SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance.

[44] Bacterial biofilms: from the Natural environment to infectious diseases

[45] Call for Papers: Infectious Disease Research in China

[46] Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections

[47] An antibiotic stewardship exercise in the ICU: building a treatment algorithm for the management of ventilator-associated pneumonia based on local epidemiology and the 2016 Infectious Diseases Society of America/American Thoracic Society guidelines

[48] Polypodium leucotomos Extract use to prevent and reduce the risk of infectious diseases in high performance athletes

[49] Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections

[50] An antibiotic stewardship exercise in the ICU: building a treatment algorithm for the management of ventilator-associated pneumonia based on local epidemiology and the 2016 Infectious Diseases Society of America/American Thoracic Society guidelines

[51] Polypodium leucotomos Extract use to prevent and reduce the risk of infectious diseases in high performance athletes

[52] Dynamic modelling of the impact of public health education on the control of emerging infectious disease

[53] Design and research of intelligent motion intervention system for infectious diseases.

[54] Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT.

[55] Recent advances in understanding and managing infectious diseases in solid organ transplant recipients.

[56] Why should we apply ABM for decision analysis for infectious diseases?-An example for dengue interventions.

[57] Complementing conventional infectious disease surveillance with national health insurance claims data in the Republic of Korea

[58] Utilizing general human movement models to predict the spread of emerging infectious diseases in resource poor settings

[59] An Analysis of Infectious Disease Research Trends in Medical Journals From North Korea

[60] Addressing Disease-Related Stigma During Infectious Disease Outbreaks.

[61] Epidemiology of MDR-TB in a belgian infectious diseases unit: A 15 years review

[62] Open Sources and Crowdsourcing for Combating Emerging and Reemerging Infectious Diseases

[63] Progress in pediatrics in 2011. Choices in endocrinology, gastroenterology, hemato-oncology, infectious diseases, otolaryngology, pharmacotherapy and respiratory tract illnesses

[64] Impacts of TV and radio advertisements on the dynamics of an infectious disease: A modeling study

[65] A Mathematical Model for the Control of Infectious Diseases: Effects of TV and Radio Advertisements

[66] Dynamic and game theory of infectious disease stigmas

[67] Renaissance of infectious diseases

[68] Technology to advance infectious disease forecasting for outbreak management.

[69] Increased sensitivity of 3D-Well enzymelinked immunosorbent assay (ELISA) for infectious disease detection using 3Dprinting fabrication technology

[70] SRA Down Under: Cache and Analysis Platform for Infectious Disease.

[71] Impact of Environmental Changes on Infectious Diseases: key findings from an international conference in Trieste, Italy in May 2017.

[72] Highlights at the 28th Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2018

[73] Distributed Microbiology Testing: Bringing Infectious Disease Diagnostics to Point of Care

[74] Latent conditional individual-level models for infectious disease modeling.

[75] Infectious disease risks from dead bodies following natural disasters Riesgo de transmisión de enfermedades infecciosas por contacto con cadáveres después de desastres naturales

[76] The Current and Future Use of Telemedicine in Infectious Diseases Practice.

[77] Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases.

[78] International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass.

[79] Phytochemical Screening, Antibacterial Activity and Heavy Metal Analysis of Ethnomedicinal Recipes and Their Sources Used Against Infectious Diseases.

[80] Multi-sectorial research is paramount for preventing and controlling emerging infectious diseases.

[81] Tuberculosis-Related Hospitalizations in a Low-Incidence Country: A Retrospective Analysis in Two Italian Infectious Diseases Wards.

[82] Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience.

[83] Review of Infectious Disease Report in Great Britain

[84] Which public health interventions are effective in reducing morbidity, mortality and health inequalities from infectious diseases amongst children in low-income and middle-income countries (LMICs): protocol for an umbrella review.

[85] [Thomas Mann and the infectious diseases in the first half of 20th. century. Second part: Tuberculosis, cholera and transplants].

[86] Systematic detection of positive selection in the human-pathogen interactome and lasting effects on infectious disease susceptibility.

[87] Can we 'WaSH' infectious diseases out of slums?

[88] The prevalence of hearing impairment in the 6 months-5 years HIV/AIDS-positive patients attending paediatric infectious disease clinic at Mulago Hospital.

[89] The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.

[90] Applications of Nanodiamonds in the Detection and Therapy of Infectious Diseases

[91] The book of infectious diseases—a living document

[92] Cell-Membrane-Mimicking Nanodecoys against Infectious Diseases.

[93] Infectious disease diagnosed by fine needle aspiration biopsy.

[94] Climate change and infectious diseases: Crossover between medical research and area informatics

[95] Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns

[96] Reporting of notifiable infectious diseases during the COVID-19 response.

[97] Impact of Mandatory Infectious Diseases Consultation and Real-time Antimicrobial Stewardship Pharmacist Intervention on Bacteremia Bundle Adherence.

[98] Short report on implications of Covid-19 and emerging zoonotic infectious diseases for pastoralists and Africa

[99] Real-time Colorimetric Quantitative Molecular Detection of Infectious Diseases on Smartphone-based Diagnostic Platform

[100] Antibiotic stewardship in the PICU: Impact of ward rounds led by paediatric infectious diseases specialists on antibiotic consumption

[101] Algorithmic discovery of dynamic models from infectious disease data